Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to evaluate the safety of MD-0727 in patients with
primary hypercholesterolemia and to determine the low density lipoprotein cholesterol (LDL-C)
lowering effect and dose-response of MD-0727 in patients with primary hypercholesterolemia.